Osteopontin expression in healing wounds of horses and in human keloids

Equine Veterinary Journal

Volumn 48, Issue 1, 2016, Pages 72-77

  Miragliotta, V ^a   Pirone, A ^a   Donadio, E ^a   Abramo, F ^a   Ricciardi, M P ^a   Theoret, C L ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Exuberant granulation tissue; Horse; Human; Keloid; Wound healing

Indexed keywords

OSTEOPONTIN;

ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HORSE; HUMAN; KELOID; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; WOUND HEALING;

ANIMALS; GENE EXPRESSION REGULATION; HORSES; HUMANS; KELOID; OSTEOPONTIN; POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 84949920791     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/evj.12372     Document Type: Article

References (38)

1. Hendrickson, D. and Virgin, J. (2005) Factors that affect equine wound repair. Vet. Clin. N. Am.: Equine Pract. 21, 33-44.
2. Theoret, C.L., Olutoye, O.O., Parnell, L.K. and Hicks, J. (2013) Equine exuberant granulation tissue and human keloids: a comparative histopathologic study. Vet. Surg. 42, 783-789.
3. Theoret, C.L. and Wilmink, J.M. (2013) Aberrant wound healing in the horse: naturally occurring conditions reminiscent of those observed in man. Wound Repair Regen. 21, 365-371.
4. Celeste, C.J., Deschene, K., Riley, C.B. and Theoret, C.L. (2011) Regional differences in wound oxygenation during normal healing in an equine model of cutaneous fibroproliferative disorder. Wound Repair Regen. 19, 89-97.
5. Kischer, C.W. (1992) The microvessels in hypertrophic scars, keloids and related lesions: a review. J. Submicrosc. Cytol. Pathol. 24, 281-296.
6. Zhang, Q., Oh, C.K., Messadi, D.V., Duong, H.S., Kelly, A.P., Soo, C., Wang, L. and Le, A.D. (2006) Hypoxia-induced HIF-1α accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt. Exp. Cell Res. 312, 145-155.
7. Blengio, F., Raggi, F., Pierobon, D., Cappello, P., Eva, A., Giovarelli, M., Varesio, L. and Bosco, M.C. (2013) The hypoxic environment reprograms the cytokine/chemokine expression profile of human mature dendritic cells. Immunobiology 218, 76-89.
8. Liaw, L., Birk, D.E., Ballas, C.B., Whitsitt, J.S., Davidson, J.M. and Hogan, B.L.M. (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101, 1468-1478.
9. Wu, M., Schneider, D.J., Mayes, M.D., Assassi, S., Arnett, F.C., Tan, F.K., Blackburn, M.R. and Agarwal, S.K. (2012) Osteopontin in systemic sclerosis and its role in dermal fibrosis. J. Invest. Dermatol. 132, 1605-1614.
10. Mori, R., Shaw, T.J. and Martin, P. (2008) Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J. Exp. Med. 205, 43-51.
11. Miragliotta, V., Lefebvre-Lavoie, J., Lussier, J.G. and Theoret, C.L. (2008) OB-cadherin cloning and expression in a model of wound repair in horses. Equine Vet. J. 40, 643-648.
12. Miragliotta, V., Lefebvre-Lavoie, J., Lussier, J.G. and Theoret, C.L. (2008) Equine ANXA2 and MMP1 expression analyses in an experimental model of normal and pathological wound repair. J. Dermatol. Sci. 51, 103-112.
13. Miragliotta, V., Ipiña, Z., Lefebvre-Lavoie, J., Lussier, J.G. and Theoret, C.L. (2008) Equine CTNNB1 and PECAM1 nucleotide structure and expression analyses in an experimental model of normal and pathological wound repair. BMC Physiol. 8, 1.
14. Miragliotta, V., Raphaël, K., Ipiña, Z., Lussier, J.G. and Theoret, C.L. (2009) Equine thrombospondinII and secreted protein acidic and cysteine-rich in a model of normal and pathological wound repair. Physiol. Genomics 38, 149-157.
15. Miragliotta, V., Raphäel, K., Lussier, J.G. and Theoret, C.L. (2009) Equine lumican (LUM) cDNA sequence and spatio-temporal expression in an experimental model of normal and pathological wound healing. Vet. Dermatol. 20, 243-248.
16. Miragliotta, V., Lussier, J.G. and Theoret, C.L. (2009) Laminin receptor1 is differentially expressed in thoracic and limb wounds in the horse. Vet. Dermatol. 20, 27-34.
17. Lepault, E., Celeste, C., Dore, M., Martineau, D. and Theoret, C.L. (2005) Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Repair Regen. 13, 520-529.
18. Theoret, C.L., Barber, S.M., Moyana, T.N. and Gordon, J.R. (2002) Preliminary observations on expression of transforming growth factors beta1 and beta3 in equine full-thickness skin wounds healing normally or with exuberant granulation tissue. Vet. Surg. 31, 266-273.
19. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
20. Xie, Y., Sakatsume, M., Nishi, S., Narita, I., Arakawa, M. and Gejyo, F. (2001) Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 60, 1645-1657.
21. Anborgh, P.H., Mutrie, J.C., Tuck, A.B. and Chambers, A.F. (2011) Pre- and post-translational regulation of osteopontin in cancer. J. Cell Commun. Signal 5, 111-122.
22. Rodrigues, L.R., Teixeira, J.A., Schmitt, F.L., Paulsson, M. and Lindmark-Mänsson, H. (2007) The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol. Biomarkers Prev. 16, 1087-1097.
23. Kiefer, M.C., Bauer, D.M. and Barr, P.J. (1989) The cDNA and derived amino acid sequence for human osteopontin. Nucleic Acids Res. 17, 3306.
24. Young, M.F., Kerr, J.M., Termine, J.D., Wewer, U.M., Wang, M.G., McBride, O.W. and Fisher, L.W. (1990) cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 7, 491-502.
25. Hijiya, N., Setoguchi, M., Matsuura, K., Higuchi, Y., Akizuki, S. and Yamamoto, S. (1994) Cloning and characterization of the human osteopontin gene and its promoter. Biochemistry 303, 255-262.
26. He, B., Mirza, M. and Weber, G.F. (2006) An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene 25, 2192-2202.
27. Mirza, M., Shaughnessy, E., Hurley, J.K., Vanpatten, K.A., Pestano, G.A., He, B. and Weber, G.F. (2008) Osteopontin-c is a selective marker of breast cancer. Int. J. Cancer 122, 889-897.
28. Chae, S., Jun, H.O., Lee, E.G., Yang, S.J., Lee, D.C., Jung, J.K., Park, K.C., Yeom, Y.I. and Kim, K.W. (2009) Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines. Int. J. Oncol. 35, 1409-1416.
29. Ivanov, S.V., Ivanova, A.V., Goparaju, C.M., Chen, Y., Beck, A. and Pass, H.I. (2009) Tumorigenic properties of alternative osteopontin isoforms in mesothelioma. Biochem. Biophys. Res. Commun. 382, 514-518.
30. Sullivan, J., Blair, L., Alnajar, A., Aziz, T., Ng, C.Y., Chipitsyna, G., Gong, Q., Witkiewicz, A., Weber, G.F., Denhardt, D.T., Yeo, C.J. and Arafat, H.A. (2009) Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma. Surgery 146, 232-240.
31. Yan, W., Qian, C., Zhao, P., Zhang, J., Shi, L., Qian, J., Liu, N., Fu, Z., Kang, C., Pu, P. and You, Y. (2010) Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells. Neuro-oncology 12, 765-775.
32. Goparaju, C.M., Pass, H.I., Blasberg, J.D., Hirsch, N. and Donington, J.S. (2010) Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer. J. Thorac. Oncol. 5, 1516-1523.
33. Hudkins, K.L., Giachelli, C.M., Cui, Y., Couser, W.G., Johnson, R.J. and Alpers, C.E. (1999) Osteopontin expression in fetal and mature human kidney. J. Am. Soc. Nephrol. 10, 444-457.
34. Wilmink, J.M., van Weeren, P.R., Stolk, P.W., Van Mil, F.N. and Barneveld, A. (1999) Differences in second-intention wound healing between horses and ponies: histological aspects. Equine Vet. J. 31, 61-67.
35. Routray, S., Kheur, S.M. and Kheur, M. (2013) Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias. Ann. Diagn. Pathol. 17, 421-424.
36. Chang, P.L., Harkins, L., Hsieh, Y.H., Hicks, P., Sappayatosok, K., Yodsanga, S., Swasdison, S., Chambers, A.F., Elmets, C.A. and Ho, K.J. (2008) Osteopontin expression in normal skin and non-melanoma skin tumors. J. Histochem. Cytochem. 56, 57-66.
37. Abdou, A.G., El Farargy, S., Seleit, I., Antar, A.G., Elhefny, M. and Elnaidany, N.F. (2012) Osteopontin expression in chronic plaque psoriasis: an association with the severity of disease. Anal. Quant. Cytol. Histol. 34, 79-85.
38. Lenga, Y., Koh, A., Perera, A.S., McCulloch, C.A., Sodek, J. and Zohar, R. (2008) Osteopontin expression is required for myofibroblast differentiation. Circ. Res. 102, 319-327.